In a 32‑year‑old woman undergoing a frozen‑embryo transfer with a 10‑mm follicle on cycle day 2, estradiol 58 pg/mL, progesterone <0.5 ng/mL, started on oral estradiol valerate (Progynova) 2 mg three times daily, now on cycle day 8 the endometrial thickness is 6.5 mm and the follicle is ~9 mm; how should we manage the cycle?

Management of Frozen Embryo Transfer Cycle with Inadequate Follicular Suppression

Cancel this cycle and restart with better baseline suppression, as the persistent follicle (9mm on day 8) indicates inadequate suppression and risks asynchrony between endometrial and embryonic development. 1, 2

Why This Cycle Should Be Cancelled

The Core Problem: Follicular Activity During Artificial Cycle

• A follicle measuring 9-10mm on cycle day 8 during an artificial FET cycle represents inadequate ovarian suppression and threatens endometrial-embryonic synchrony. 1, 3
• The presence of an active follicle means endogenous estrogen production is competing with your exogenous estradiol (Progynova), creating unpredictable hormonal milieu. 1, 4
• If this follicle ovulates, corpus luteum formation will produce progesterone prematurely, causing the endometrium to advance beyond the proliferative phase before you initiate progesterone supplementation for transfer. 1, 2
• The endometrial thickness of 6.5mm on day 8 is suboptimal and suggests the exogenous estrogen is not adequately preparing the endometrium, likely because the follicle is interfering with the artificial cycle protocol. 5

Evidence Against Continuing

• Artificial cycles require complete ovarian suppression to work properly—the entire premise is replacing natural hormonal production with exogenous hormones in a controlled, predictable manner. 1, 4
• Studies comparing natural versus artificial cycles demonstrate that artificial cycles only achieve comparable outcomes when properly executed with adequate suppression. 5, 4
• Transcriptome analysis shows that artificial cycles already have inferior endometrial gene expression patterns compared to natural cycles; adding the chaos of an unsuppressed follicle further compromises receptivity. 4

Correct Protocol for Next Cycle

Baseline Assessment Requirements

• On cycle day 2-3 of the next cycle, perform ultrasound to confirm NO follicles >10mm and measure estradiol to confirm <50 pg/mL before starting estrogen. 1, 2
• If a follicle >10mm is present at baseline, either wait for it to regress or consider switching to a modified natural cycle protocol instead. 2, 3

Estrogen Dosing Strategy

• Continue Progynova 2mg three times daily (6mg total daily), but only after confirming adequate baseline suppression. 5
• If endometrial thickness remains <7mm on day 9-10 of the properly suppressed cycle, switch to vaginal estradiol supplementation (this improves pregnancy rates from 13% to 31% compared to oral alone). 5
• Target endometrial thickness is ≥7-8mm before initiating progesterone. 5, 3

Monitoring Schedule

• Day 2-3: Baseline ultrasound and estradiol (must be suppressed). 1, 2
• Day 9-10: Check endometrial thickness and confirm no follicular development. 5, 3
• Day 12-14: Final check before initiating progesterone (endometrium should be ≥7mm, no follicles). 1, 5

Alternative: Consider Modified Natural Cycle

When to Switch Protocols

• If this patient repeatedly develops follicles during attempted artificial cycles, a modified natural cycle FET may be superior. 2, 3
• Recent evidence (2025) strongly favors natural cycle FET over artificial cycles due to lower rates of preeclampsia and better obstetric outcomes, particularly when ovarian function is intact. 2, 3
• Natural cycles avoid the transcriptional abnormalities seen with artificial hormone replacement. 4

Modified Natural Cycle Protocol

• Monitor for dominant follicle development with ultrasound starting cycle day 10-12. 3
• Trigger ovulation with hCG when follicle reaches 18-20mm. 3
• Begin progesterone supplementation 2-3 days after trigger (for day 3 embryos) or 5-6 days after trigger (for blastocysts). 1, 3
• This provides both the physiologic benefits of corpus luteum presence AND the scheduling flexibility of controlled ovulation timing. 3

Critical Embryo Transfer Recommendation

Mandatory Single Embryo Transfer

• Regardless of which endometrial preparation protocol you ultimately use, transfer only ONE blastocyst. 6, 7
• ESHRE provides a strong recommendation that elective single embryo transfer (eSET) must be practiced for all blastocyst transfers, with no exceptions based on previous failed cycles, patient age, or endometrial characteristics. 6, 7
• Double embryo transfer increases multiple pregnancy risk 30-fold (OR 30.54,95% CI 7.46-124.95) without improving cumulative live birth rates. 7

Common Pitfalls to Avoid

• Do not attempt to "push through" this cycle by increasing estrogen dose—the problem is the unsuppressed follicle, not inadequate estrogen dosing. 1, 4
• Do not transfer two embryos thinking it will compensate for suboptimal endometrial preparation—this only adds multiple pregnancy risk without improving outcomes. 6, 7
• Do not ignore the follicle hoping it will spontaneously regress—it is likely to ovulate and ruin synchronization. 1, 2